PLEASANTON, CA--(MARKET WIRE)--Aug 6, 2007 -- Lipid Sciences, Inc. (NasdaqGM:LIPD - News) today reported financial results for the second quarter and six months ended June 30, 2007. For the second quarter of 2007, the Company reported a net loss of $2.7 million, or $0.07 per share on a basic and diluted basis. This compares with a net loss of $2.6 million, or $0.09 per share, on a basic and diluted basis, for the same period in 2006. Included in the net loss for the second quarter 2007 is revenue of $137,000 related to a collaborative research agreement with Elanco Animal Health, a division of Eli Lilly and Company.
